Resveratrol inhibits cell growth in a human cholangiocarcinoma cell line.

Roncoroni, Leda; Elli, Luca; Dolfini, Ersilia; Erba, Eugenio; Dogliotti, Elena; Terrani, Claudia; Doneda, Luisa; Grimoldi, Maria Grazia; Bardella, Maria Teresa

Roncoroni, Leda; Elli, Luca; Dolfini, Ersilia; Erba, Eugenio; Dogliotti, Elena; Terrani, Claudia; Doneda, Luisa; Grimoldi, Maria Grazia; Bardella, Maria Teresa.

Affiliation

Roncoroni L; Center for Prevention and Diagnosis of Celiac Disease, IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milano, Italy.

Liver Int ; 28(10): 1426-36, 2008 Dec.

Article in En | MEDLINE | ID: mdl-18397227

Subject(s)

Cholangiocarcinoma/drug therapy; Stilbenes/pharmacology; Alkaline Phosphatase/metabolism; Cell Line, Tumor; Cell Survival/drug effects; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Enzyme Activation/drug effects; Flow Cytometry; Fluorescent Antibody Technique; Humans; Karyotyping; L-Lactate Dehydrogenase/metabolism; Microscopy, Electron, Scanning; Resveratrol; Transglutaminases/metabolism

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stilbenes / Cholangiocarcinoma Limits: Humans Language: En Journal: Liver Int Journal subject: GASTROENTEROLOGIA Year: 2008 Document type: Article Affiliation country: Italy Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google